Gaillac, France

Michael Briley


Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Castres, FR (1997)
  • Gaillac, FR (1997 - 1999)

Company Filing History:


Years Active: 1997-1999

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Michael Briley: Innovator in Parkinson's Disease Treatment

Introduction

Michael Briley is a notable inventor based in Gaillac, France. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of neurological disorders. With a total of 4 patents to his name, Briley's work focuses on innovative solutions for complex health issues.

Latest Patents

One of Briley's latest patents involves the treatment of Parkinson's disease. The invention relates to the use of efaroxan and its derivatives for the preparation of a medicinal product intended for this purpose. Additionally, he has developed indole-derived arylpiperazines as ligands for 5HT.sub.1 -like receptors, showcasing his commitment to advancing therapeutic options for patients.

Career Highlights

Briley is currently associated with Pierre Fabre Medicament, a prominent company in the pharmaceutical industry. His work there emphasizes the importance of research and development in creating effective treatments for debilitating conditions. His innovative approach has garnered attention in the scientific community.

Collaborations

Throughout his career, Briley has collaborated with esteemed colleagues such as Serge Halazy and Michel Perez. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Michael Briley stands out as a dedicated inventor whose work in the treatment of Parkinson's disease has the potential to make a significant impact on patient care. His innovative spirit and collaborative efforts continue to drive advancements in the pharmaceutical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…